Differences between Influenza A, Influenza B, and Nucleic Acid Testing

Both viral IgM and IgG antibody tests and nucleic acid testing are methods used to detect viruses and determine the presence of a virus. Influenza B antibody testing can determine whether an individual has been infected by the virus, while nucleic acid testing detects whether the virus is present. Influenza A antibody testing measures the levels of anti-influenza A antibodies in an individual's serum to assess prior infection with the influenza A virus. Higher antibody levels indicate previous exposure to influenza A and stronger immunity, whereas lower levels suggest prior exposure but weaker immunity, potentially increasing the risk of reinfection. Influenza B antibody testing is similar to influenza A antibody testing—it evaluates the level of anti-influenza B antibodies to determine if there has been a past influenza B infection, with higher antibody levels indicating stronger immunity and lower levels indicating weaker immunity. Nucleic acid testing detects viral nucleic acid levels, primarily targeting viral RNA. This method accurately identifies whether an individual has been exposed to the virus and is commonly used to confirm viral infections, such as in the case of SARS-CoV-2 nucleic acid testing for COVID-19. In summary, influenza A and B antibody tests reveal whether someone has previously been exposed to the virus, while nucleic acid testing determines whether the virus is currently present—these two approaches have clear differences.